Medical marijuana

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

Medical marijuana or medical cannabis refers to the use of cannabis or derivatives of cannabis plants to treat medical illnesses or reduce symptoms.[1] Medical marijuana typically contains both CBD and THC, which are two of the many biologically active substances found in cannabis.[2][3] CBD, which is not intoxicating or addictive, can also be produced from hemp plants, and is often marketed as CBD oil and sold legally as a without needing a perscription.[1][citation needed]

Evidence[edit | edit source]

A review by Whiting et al. (2015) found moderate evidence that medical use of cannabis can help with chronic pain, but this review did not look at pain in ME/CFS.[4]

Limited evidence is available for the use of cannabis or medical marijuana in people with Fibromyalgia.[5][6]

Notable studies[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. 1.01.1 "Definition of MEDICAL MARIJUANA". Retrieved Apr 11, 2019. 
  2. "Definition of THC". Retrieved Apr 11, 2019. 
  3. "Definition of CBD". Retrieved Apr 11, 2019. 
  4. Whiting, Penny F.; Wolff, Robert F.; Deshpande, Sohan; Di Nisio, Marcello; Duffy, Steven; Hernandez, Adrian V.; Keurentjes, J. Christiaan; Lang, Shona; Misso, Kate (Jun 23, 2015). "Cannabinoids for Medical Use". JAMA. 313 (24): 2456. doi:10.1001/jama.2015.6358. ISSN 0098-7484. 
  5. 5.05.1 Farré, Magí; Carbonell, Jordi; Capellà, Dolors; Durán, Marta; Fiz, Jimena (Apr 21, 2011). "Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life". PLOS ONE. 6 (4): e18440. doi:10.1371/journal.pone.0018440. ISSN 1932-6203. PMC 3080871Freely accessible. PMID 21533029. 
  6. 6.06.1 van de Donk, Tine; Niesters, Marieke; Kowal, Mikael A.; Olofsen, Erik; Dahan, Albert; van Velzen, Monique (Apr 2019). "An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia". PAIN. 160 (4): 860. doi:10.1097/j.pain.0000000000001464. ISSN 0304-3959. 
  7. Ryan, Duncan; Drysdale, Alison J.; Lafourcade, Carlos; Pertwee, Roger G.; Platt, Bettina (Feb 18, 2009), "Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels", The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 29 (7): 2053–2063, doi:10.1523/JNEUROSCI.4212-08.2009, ISSN 1529-2401, PMID 19228959 
  8. Jadoon, Khalid A.; Ratcliffe, Stuart H.; Barrett, David A.; Thomas, E. Louise; Stott, Colin; Bell, Jimmy D.; O’Sullivan, Saoirse E.; Tan, Garry D. (Aug 29, 2016), "Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study", Diabetes Care: American Diabetes Association, 39 (10): 1777–86, doi:10.2337/dc16-0650 

Myalgic encephalomyelitis or chronic fatigue syndrome

The information provided at this site is not intended to diagnose or treat any illness.

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history